Publications
Quick Links
Read the Full Issue (Members Only)
Past Free Issues
- Rx Distribution Licenses: A Matter of State
- U.S. FDA IDs Solutions to Drug Shortages
- Save Money by Attending TRI Courses
- Lack of Compendia Harmony for Visible Particles Causing Confusion
- Audit Program Part of FDA Pathway for Global Product Safety
- Progress of the Quality Topics at the ICH Meeting in Seville
- New Participation Opportunity: Nominate a BoD Candidate
- First PCMO TR Coming in March
- Interview with James Akers On Revised USP <1116>
- U.S. FDA Paves the Way for Biosimilars in US
About PDA Letter
The PDA Letter is PDA's membership publication covering the science, technology, quality, regulatory affairs and association news and updates relevant to the PDA community. It publishes 10 times per year, with issues in January, February, March, April, May, June, September and October, as well as two larger issues for July/August and November/December.
The PDA Letter is divided into seven sections, one for each PDA department and a features section. Feature articles are supplied by PDA members, industry and regulatory experts and occasionally by PDA staff. The PDA Letter Editorial Committee (PLEC) provides editorial oversight for all feature articles.
PDA Letter Editorial Committee
Vincent Anicetti, Genentech
Harold Baseman, ValSource
John Paul Bevel, Teva Pharma
Winston Brown, Baxter
José A. Caraballo, Amgen
Robert Darius, GlaxoSmithKline
Mitchell Ehrlich, Fresenius-Kabi
Martha Folmsbee, Pall
Karen Ginsbury, PCI Pharmaceutical Consulting
Anastasia Lolas, Visionary Pharma Consulting
Rainer Newman
Susan Schniepp, OSO BioPharma Manufacturing
Janeen Skutnik-Wilkinson, Pfizer
Kathleen O’Sulivan, BD
Sarah Thomas, Human Genome Sciences
Sandra Zoghbi-Gay, bioMérieux
PDA Letter Staff
Walter Morris, Director of Publishing
Tel: (301) 656-5900 x148
E-mail: morris@pda.org
Emily Hough, Assistant Editor
Tel: (301)656-5900 x139
E-mail: hough@pda.org
Katja Yount, Publication Design Specialist
Tel: (301) 656-5900 x161
E-mail: yount@pda.org